RAKHEE AJMERA: Open Payments
NPI 1255658902 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 20 payments from 7 companies in 2025. Trend: 2023 $228 · 2024 $726 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $183 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $120 |
| Novartis Pharmaceuticals Corporation | 6 | $107 |
| PFIZER INC. | 2 | $51 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: JARDIANCE, LifeVest, LEQVIO, ELIQUIS, ENTRESTO, ZEPBOUND, AREXVY.
Industry payments across PA — which companies pay providers there.
